- $3.45bn
- $3.08bn
- $379.81m
Transplant diagnostics firm CareDx Q3 revenue beats estimates, helped by new product launches
Brief: CareDx Q3 Adjusted EPS USD 0.28 Vs. IBES Estimate USD 0.14
Brief: Caredx Announces Appointment Of Suresh Gunasekaran To Board Of Directors
Brief: CareDx Submits Comment Letter On Draft LCD For Molecular Testing For Solid Organ Transplant Rejection
U.S. RESEARCH ROUNDUP-Applovin, Costco Wholesale, Hubspot
CareDx Inc reports results for the quarter ended June 30 - Earnings Summary
CareDx Q2 adjusted revenue grows 14%
Brief: CareDx Announces Repurchase Of 5% Of Outstanding Shares
CareDx Inc reports results for the quarter ended March 31 - Earnings Summary
Brief: CareDx Q1 Adjusted EPS USD 0.09 Vs. IBES Estimate USD 0.06
CareDx Inc reports results for the quarter ended December 31 - Earnings Summary
Natera falls as $96 mln patent verdict overturned
CareDx gets $96 million jury win for Natera overturned
CareDx Inc reports results for the quarter ended in September 30 - Earnings Summary
Brief: CareDx Q3 Adjusted EPS USD 0.14 Vs. IBES Estimate USD 0.01
Brief: CareDx Reports Preliminary Financial Results For Third Quarter 2024
Brief: CareDx Announces Closure Of DOJ Investigation With No Finding Of Wrongdoing
Brief: Caredx Appoints Keith Kennedy Chief Operating Officer And Jessica Meng Chief Commercial Officer
U.S. RESEARCH ROUNDUP- Agree Realty, Global Payments, Snowflake